Home/Filings/4/0001104659-25-052122
4//SEC Filing

Hoffman Robert E. 4

Accession 0001104659-25-052122

CIK 0001175680other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 8:31 PM ET

Size

6.0 KB

Accession

0001104659-25-052122

Insider Transaction Report

Form 4
Period: 2025-05-15
HOFFMAN ROBERT
Chief Financial Officer
Transactions
  • Award

    Non-qualified stock option (right to buy)

    2025-05-15+1,000,0001,000,000 total
    Exercise: $0.41Exp: 2035-05-15Common Stock (1,000,000 underlying)
Footnotes (2)
  • [F1]This grant was approved by the Company's Compensation Committee effective May 15, 2025, pursuant to the Issuer's 2012 Equity Incentive Plan, as amended (the "Plan").
  • [F2]250,000 shares will vest on May 15, 2026, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Plan ) from May 2026 through April 2029.

Issuer

CytoDyn Inc.

CIK 0001175680

Entity typeother

Related Parties

1
  • filerCIK 0001166288

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 8:31 PM ET
Size
6.0 KB